Regulatory changes: the experts give us their thoughts at DIA Euromeeting

By Natalie Morrison

- Last updated on GMT

Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark.

Outsourcing-Pharma spoke to some of the industry’s leading experts to get their opinion on the matter, and it seemed that for most, a change is welcome.

We asked just one question: “What should be the key focus for regulatory reform, and do you think changes in the pipeline are for the better?”

But with firms from different ends of the pharmaceutical spectrum, opinions on exactly what should be changed were a mixed bag.

Clinipace’s senior director and head of regulatory affairs Franck Wierckx thinks we will see a big impact in the field of pharmacovigilance when planned changes in regulations take effect.

Karel Bastiaanssen CEO and co-founder of Phrisma said there is a need for focus on data management.

Meanwhile CEO and founder of regulatory advisor the Weinberg Group, Matthew Weinberg, told us advancements in personalisation will pose the biggest challenge for the US FDA (Food and Drug Administration) in particular.

And Carolyn Finkle, Catalent’s VP of global regulatory consulting, foresees harmonisation in technology assessment as the way forward.

Related news

Show more

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers